Skip to content
The Policy VaultThe Policy Vault

naproxen/esomeprazole delayed-release tabletsCigna

treatment of acute and chronic conditions requiring analgesic and anti-inflammatory activity

Preferred products

  • prescription naproxen sodium
  • prescription naproxen
  • prescription dexlansoprazole
  • prescription esomeprazole magnesium
  • prescription esomeprazole strontium
  • prescription lansoprazole
  • prescription omeprazole
  • prescription omeprazole/sodium bicarbonate
  • prescription pantoprazole
  • prescription rabeprazole

Initial criteria

  • Patient has tried one prescription naproxen product (Step 1b) AND one prescription proton pump inhibitor (Step 1b) prior to use of naproxen/esomeprazole delayed-release tablets (Step 2b)

Approval duration

1 year